Gen AI’s real opportunity in drug development? As a smart, strategic decision aid

Perspectives from pharma leaders on how we enable AI models to produce high quality outputs to ensure data accessibility and usability.

In this blog post, we dive into the insights shared by pharma experts on the promise AI holds for addressing these challenges.

A recent study published in Journal of Translational Medicine illustrates how the integration of knowledge graph-driven insights into survival prediction and biomarker discovery paves the way for more precise personalised cancer treatments.